 |
Summary Table: Treatment – Bladder, Breast, Colorectal
|
|
Only one measure per topic is displayed in the summary table. A complete set of measures, where they exist, can be found in the report.
| Trend key: |
 |
green - headed in the right direction |
| |
 |
red - headed in the wrong direction |
| |
 |
black - stable or non-significant change (NSC) |
| |
 |
blue - Healthy People 2010 target |
| |
Bladder cancer treatment
1995 and 2003 |
Breast cancer treatment:
Breast-conserving surgery and radiation
1992–2006 |
Breast cancer treatment:
Multi-agent chemotherapy
1987–2005 |
Colorectal cancer treatment
1987–2005 |
| Measure |
Percentage of individuals receiving intravesical therapy in non-muscle invasive bladder cancer. |
Percentage of women aged 20 years and older, diagnosed with early-stage breast cancer (less than stage IIIA), receiving breast-conserving surgery and radiation treatment. |
Percentage of women aged 20 years and older, diagnosed with node positive, stage I–IIIA breast cancer, receiving multi-agent chemotherapy. |
Percentage of individuals, aged 20 years and older, diagnosed with stage III colon cancer who received chemotherapy or diagnosed with stage II or stage III rectal cancer who received chemotherapy with or without radiotherapy. |
| Recent summary trend* |
Rising
1995–2003 |
Rising
1999–2003 |
Rising
2001–2005 |
Rising
2001–2005 |
| Desired direction |
Rising  |
Rising  |
Rising  |
Rising  |
| Trend |
Rising
 |
Rising
 |
Rising
|
Rising

|
| Most recent estimate |
In 2003, 27 percent of patients with non-muscle invasive disease received intravesical therapy. |
In 2006, 35 percent of women aged 20 years and older diagnosed with early-stage breast cancer (less than stage IIIA) received mastectomy, 42 percent received breast-conserving surgery plus radiation, and 21 percent received breast-conserving surgery only. |
In 2005, 67 percent of women aged 20 years and older, diagnosed with node positive breast cancer, received multi-agent chemotherapy. |
In 2005, 60 percent of stage III colon and stage II and III rectal patients aged 65 years and older received adjuvant chemotherapy, while more than 85 percent of patients aged 20 to 64 received chemotherapy. |
| Healthy People 2010 target |
There is no Healthy People 2010 target for bladder cancer treatment. |
There is no Healthy People 2010 target for breast-conserving surgery and radiation treatment. |
There is no Healthy People 2010 target for multi-agent chemotherapy treatment. |
There is no Healthy People 2010 target for colorectal cancer treatment. |
| More information |
|
|
|